DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Takakura S, Toyoshi T, Hayashizaki Y. et al.
Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats.
Life Sci 2016;
147: 125-131
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.